世界のAGK抗体市場予測 2023年-2029年

【英語タイトル】Global AGK Antibody Market Growth 2023-2029

LP Informationが出版した調査資料(LP23DC08470)・商品コード:LP23DC08470
・発行会社(調査会社):LP Information
・発行日:2023年11月(※2025年版があります。お問い合わせください。)
・ページ数:125
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医薬品&医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥519,720見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥779,580見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,039,440見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のAGK抗体市場」は、過去の販売実績から2022年の世界のAGK抗体の総販売量を検討し、2023年から2029年の予測されるAGK抗体の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のAGK抗体の市場規模を掲載し、XXX百万米ドル規模の世界のAGK抗体市場の詳細な分析を提供します。本インサイトレポートは、世界のAGK抗体業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のAGK抗体市場における各社の独自のポジションをより深く理解するために、AGK抗体製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のAGK抗体市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。AGK抗体の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000%と予測されています。AGK抗体の中国市場は、2023年から2029年までの年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。AGK抗体のヨーロッパ市場は、2023年から2029年にかけて年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

AGK抗体の世界主要メーカーとしては、Merck、 Thermo Fisher Scientific、 LifeSpan BioSciences、 Aviva Systems Biology、 RayBiotech、 ProSci、 OriGene Technologies、 ABclonal Technology、 Affinity Biosciences、 Abbexa、 Cell Signaling Technology、 CUSABIO Technology、 GeneTex、 Leading Biology、 Novus Biologicals、 G Biosciences、 Santa Cruz Biotechnology、 Biomatik、 Biobyt、 Jingjie PTM BioLabなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000%のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のAGK抗体市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではAGK抗体市場をセグメンテーションし、種類別 (モノクローナル、ポリクローナル)、用途別 (免疫化学(IHC)、免疫蛍光(IF)、免疫沈降(IP)、ウェスタンブロット(WB)、ELISA、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分:モノクローナル、ポリクローナル

・用途別区分:免疫化学(IHC)、免疫蛍光(IF)、免疫沈降(IP)、ウェスタンブロット(WB)、ELISA、その他

・地域別区分
南北アメリカ(アメリカ、カナダ、メキシコ、ブラジル)
アジア太平洋(中国、日本、韓国、東南アジア、インド、オーストラリア)
ヨーロッパ(ドイツ、フランス、イギリス、イタリア、ロシア)
中東・アフリカ(エジプト、南アフリカ、イスラエル、トルコ、GCC諸国)

【本レポートで扱う主な質問】

・世界のAGK抗体市場の10年間の市場状況・展望は?
・世界および地域別に見たAGK抗体市場成長の要因は何か?
・AGK抗体の市場機会はエンドマーケットの規模によってどのように変化するのか?
・AGK抗体のタイプ別、用途別の内訳は?
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は?

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要:AGK抗体の年間販売量2018-2029、地域別現状・将来分析
・AGK抗体の種類別セグメント:モノクローナル、ポリクローナル
・AGK抗体の種類別販売量:2018-2023年の販売量、売上、市場シェア、販売価格
・AGK抗体の用途別セグメント:免疫化学(IHC)、免疫蛍光(IF)、免疫沈降(IP)、ウェスタンブロット(WB)、ELISA、その他
・AGK抗体の用途別販売量:2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のAGK抗体市場
・企業別のグローバルAGK抗体市場データ:2018-2023年の年間販売量、市場シェア
・企業別のAGK抗体の年間売上:2018-2023年の売上、市場シェア
・企業別のAGK抗体販売価格
・主要企業のAGK抗体生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

AGK抗体の地域別レビュー
・地域別のAGK抗体市場規模2018-2023:年間販売量、売上
・主要国別のAGK抗体市場規模2018-2023:年間販売量、売上
・南北アメリカのAGK抗体販売の成長
・アジア太平洋のAGK抗体販売の成長
・ヨーロッパのAGK抗体販売の成長
・中東・アフリカのAGK抗体販売の成長

南北アメリカ市場
・南北アメリカの国別のAGK抗体販売量、売上(2018-2023)
・南北アメリカのAGK抗体の種類別販売量
・南北アメリカのAGK抗体の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のAGK抗体販売量、売上(2018-2023)
・アジア太平洋のAGK抗体の種類別販売量
・アジア太平洋のAGK抗体の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のAGK抗体販売量、売上(2018-2023)
・ヨーロッパのAGK抗体の種類別販売量
・ヨーロッパのAGK抗体の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のAGK抗体販売量、売上(2018-2023)
・中東・アフリカのAGK抗体の種類別販売量
・中東・アフリカのAGK抗体の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・AGK抗体の製造コスト構造分析
・AGK抗体の製造プロセス分析
・AGK抗体の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル:直接販売チャンネル、間接販売チャンネル
・AGK抗体の主要なグローバル販売業者
・AGK抗体の主要なグローバル顧客

地域別のAGK抗体市場予測レビュー
・地域別のAGK抗体市場規模予測(2024-2029)
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・AGK抗体の種類別市場規模予測
・AGK抗体の用途別市場規模予測

主要企業分析
Merck、 Thermo Fisher Scientific、 LifeSpan BioSciences、 Aviva Systems Biology、 RayBiotech、 ProSci、 OriGene Technologies、 ABclonal Technology、 Affinity Biosciences、 Abbexa、 Cell Signaling Technology、 CUSABIO Technology、 GeneTex、 Leading Biology、 Novus Biologicals、 G Biosciences、 Santa Cruz Biotechnology、 Biomatik、 Biobyt、 Jingjie PTM BioLab
・企業情報
・AGK抗体製品
・AGK抗体販売量、売上、価格、粗利益(2018-2023)
・主要ビジネス概要
・最新動向

調査結果および結論

The global AGK Antibody market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
Growing patient base, launch of AGK antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in AGK antibody market revenue.
AGK antibody is a mouse, rabbit, pig and human antibody against AGK. AGK was recognized in immunohistochemical staining and western blot.
LPI (LP Information)’ newest research report, the “AGK Antibody Industry Forecast” looks at past sales and reviews total world AGK Antibody sales in 2022, providing a comprehensive analysis by region and market sector of projected AGK Antibody sales for 2023 through 2029. With AGK Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AGK Antibody industry.
This Insight Report provides a comprehensive analysis of the global AGK Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on AGK Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global AGK Antibody market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AGK Antibody and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AGK Antibody.
This report presents a comprehensive overview, market shares, and growth opportunities of AGK Antibody market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Monoclonal
Polyclonal
Segmentation by application
Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Merck
Thermo Fisher Scientific
LifeSpan BioSciences
Aviva Systems Biology
RayBiotech
ProSci
OriGene Technologies
ABclonal Technology
Affinity Biosciences
Abbexa
Cell Signaling Technology
CUSABIO Technology
GeneTex
Leading Biology
Novus Biologicals
G Biosciences
Santa Cruz Biotechnology
Biomatik
Biobyt
Jingjie PTM BioLab
Key Questions Addressed in this Report
What is the 10-year outlook for the global AGK Antibody market?
What factors are driving AGK Antibody market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do AGK Antibody market opportunities vary by end market size?
How does AGK Antibody break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global AGK Antibody Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for AGK Antibody by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for AGK Antibody by Country/Region, 2018, 2022 & 2029
2.2 AGK Antibody Segment by Type
2.2.1 Monoclonal
2.2.2 Polyclonal
2.3 AGK Antibody Sales by Type
2.3.1 Global AGK Antibody Sales Market Share by Type (2018-2023)
2.3.2 Global AGK Antibody Revenue and Market Share by Type (2018-2023)
2.3.3 Global AGK Antibody Sale Price by Type (2018-2023)
2.4 AGK Antibody Segment by Application
2.4.1 Immunochemistry (IHC)
2.4.2 Immunofluorescence (IF)
2.4.3 Immunoprecipitation (IP)
2.4.4 Western Blot (WB)
2.4.5 ELISA
2.4.6 Others
2.5 AGK Antibody Sales by Application
2.5.1 Global AGK Antibody Sale Market Share by Application (2018-2023)
2.5.2 Global AGK Antibody Revenue and Market Share by Application (2018-2023)
2.5.3 Global AGK Antibody Sale Price by Application (2018-2023)
3 Global AGK Antibody by Company
3.1 Global AGK Antibody Breakdown Data by Company
3.1.1 Global AGK Antibody Annual Sales by Company (2018-2023)
3.1.2 Global AGK Antibody Sales Market Share by Company (2018-2023)
3.2 Global AGK Antibody Annual Revenue by Company (2018-2023)
3.2.1 Global AGK Antibody Revenue by Company (2018-2023)
3.2.2 Global AGK Antibody Revenue Market Share by Company (2018-2023)
3.3 Global AGK Antibody Sale Price by Company
3.4 Key Manufacturers AGK Antibody Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers AGK Antibody Product Location Distribution
3.4.2 Players AGK Antibody Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for AGK Antibody by Geographic Region
4.1 World Historic AGK Antibody Market Size by Geographic Region (2018-2023)
4.1.1 Global AGK Antibody Annual Sales by Geographic Region (2018-2023)
4.1.2 Global AGK Antibody Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic AGK Antibody Market Size by Country/Region (2018-2023)
4.2.1 Global AGK Antibody Annual Sales by Country/Region (2018-2023)
4.2.2 Global AGK Antibody Annual Revenue by Country/Region (2018-2023)
4.3 Americas AGK Antibody Sales Growth
4.4 APAC AGK Antibody Sales Growth
4.5 Europe AGK Antibody Sales Growth
4.6 Middle East & Africa AGK Antibody Sales Growth
5 Americas
5.1 Americas AGK Antibody Sales by Country
5.1.1 Americas AGK Antibody Sales by Country (2018-2023)
5.1.2 Americas AGK Antibody Revenue by Country (2018-2023)
5.2 Americas AGK Antibody Sales by Type
5.3 Americas AGK Antibody Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC AGK Antibody Sales by Region
6.1.1 APAC AGK Antibody Sales by Region (2018-2023)
6.1.2 APAC AGK Antibody Revenue by Region (2018-2023)
6.2 APAC AGK Antibody Sales by Type
6.3 APAC AGK Antibody Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe AGK Antibody by Country
7.1.1 Europe AGK Antibody Sales by Country (2018-2023)
7.1.2 Europe AGK Antibody Revenue by Country (2018-2023)
7.2 Europe AGK Antibody Sales by Type
7.3 Europe AGK Antibody Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa AGK Antibody by Country
8.1.1 Middle East & Africa AGK Antibody Sales by Country (2018-2023)
8.1.2 Middle East & Africa AGK Antibody Revenue by Country (2018-2023)
8.2 Middle East & Africa AGK Antibody Sales by Type
8.3 Middle East & Africa AGK Antibody Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of AGK Antibody
10.3 Manufacturing Process Analysis of AGK Antibody
10.4 Industry Chain Structure of AGK Antibody
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 AGK Antibody Distributors
11.3 AGK Antibody Customer
12 World Forecast Review for AGK Antibody by Geographic Region
12.1 Global AGK Antibody Market Size Forecast by Region
12.1.1 Global AGK Antibody Forecast by Region (2024-2029)
12.1.2 Global AGK Antibody Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global AGK Antibody Forecast by Type
12.7 Global AGK Antibody Forecast by Application
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck AGK Antibody Product Portfolios and Specifications
13.1.3 Merck AGK Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Thermo Fisher Scientific
13.2.1 Thermo Fisher Scientific Company Information
13.2.2 Thermo Fisher Scientific AGK Antibody Product Portfolios and Specifications
13.2.3 Thermo Fisher Scientific AGK Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Thermo Fisher Scientific Main Business Overview
13.2.5 Thermo Fisher Scientific Latest Developments
13.3 LifeSpan BioSciences
13.3.1 LifeSpan BioSciences Company Information
13.3.2 LifeSpan BioSciences AGK Antibody Product Portfolios and Specifications
13.3.3 LifeSpan BioSciences AGK Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 LifeSpan BioSciences Main Business Overview
13.3.5 LifeSpan BioSciences Latest Developments
13.4 Aviva Systems Biology
13.4.1 Aviva Systems Biology Company Information
13.4.2 Aviva Systems Biology AGK Antibody Product Portfolios and Specifications
13.4.3 Aviva Systems Biology AGK Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Aviva Systems Biology Main Business Overview
13.4.5 Aviva Systems Biology Latest Developments
13.5 RayBiotech
13.5.1 RayBiotech Company Information
13.5.2 RayBiotech AGK Antibody Product Portfolios and Specifications
13.5.3 RayBiotech AGK Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 RayBiotech Main Business Overview
13.5.5 RayBiotech Latest Developments
13.6 ProSci
13.6.1 ProSci Company Information
13.6.2 ProSci AGK Antibody Product Portfolios and Specifications
13.6.3 ProSci AGK Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 ProSci Main Business Overview
13.6.5 ProSci Latest Developments
13.7 OriGene Technologies
13.7.1 OriGene Technologies Company Information
13.7.2 OriGene Technologies AGK Antibody Product Portfolios and Specifications
13.7.3 OriGene Technologies AGK Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 OriGene Technologies Main Business Overview
13.7.5 OriGene Technologies Latest Developments
13.8 ABclonal Technology
13.8.1 ABclonal Technology Company Information
13.8.2 ABclonal Technology AGK Antibody Product Portfolios and Specifications
13.8.3 ABclonal Technology AGK Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 ABclonal Technology Main Business Overview
13.8.5 ABclonal Technology Latest Developments
13.9 Affinity Biosciences
13.9.1 Affinity Biosciences Company Information
13.9.2 Affinity Biosciences AGK Antibody Product Portfolios and Specifications
13.9.3 Affinity Biosciences AGK Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Affinity Biosciences Main Business Overview
13.9.5 Affinity Biosciences Latest Developments
13.10 Abbexa
13.10.1 Abbexa Company Information
13.10.2 Abbexa AGK Antibody Product Portfolios and Specifications
13.10.3 Abbexa AGK Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Abbexa Main Business Overview
13.10.5 Abbexa Latest Developments
13.11 Cell Signaling Technology
13.11.1 Cell Signaling Technology Company Information
13.11.2 Cell Signaling Technology AGK Antibody Product Portfolios and Specifications
13.11.3 Cell Signaling Technology AGK Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Cell Signaling Technology Main Business Overview
13.11.5 Cell Signaling Technology Latest Developments
13.12 CUSABIO Technology
13.12.1 CUSABIO Technology Company Information
13.12.2 CUSABIO Technology AGK Antibody Product Portfolios and Specifications
13.12.3 CUSABIO Technology AGK Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 CUSABIO Technology Main Business Overview
13.12.5 CUSABIO Technology Latest Developments
13.13 GeneTex
13.13.1 GeneTex Company Information
13.13.2 GeneTex AGK Antibody Product Portfolios and Specifications
13.13.3 GeneTex AGK Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 GeneTex Main Business Overview
13.13.5 GeneTex Latest Developments
13.14 Leading Biology
13.14.1 Leading Biology Company Information
13.14.2 Leading Biology AGK Antibody Product Portfolios and Specifications
13.14.3 Leading Biology AGK Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Leading Biology Main Business Overview
13.14.5 Leading Biology Latest Developments
13.15 Novus Biologicals
13.15.1 Novus Biologicals Company Information
13.15.2 Novus Biologicals AGK Antibody Product Portfolios and Specifications
13.15.3 Novus Biologicals AGK Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Novus Biologicals Main Business Overview
13.15.5 Novus Biologicals Latest Developments
13.16 G Biosciences
13.16.1 G Biosciences Company Information
13.16.2 G Biosciences AGK Antibody Product Portfolios and Specifications
13.16.3 G Biosciences AGK Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 G Biosciences Main Business Overview
13.16.5 G Biosciences Latest Developments
13.17 Santa Cruz Biotechnology
13.17.1 Santa Cruz Biotechnology Company Information
13.17.2 Santa Cruz Biotechnology AGK Antibody Product Portfolios and Specifications
13.17.3 Santa Cruz Biotechnology AGK Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Santa Cruz Biotechnology Main Business Overview
13.17.5 Santa Cruz Biotechnology Latest Developments
13.18 Biomatik
13.18.1 Biomatik Company Information
13.18.2 Biomatik AGK Antibody Product Portfolios and Specifications
13.18.3 Biomatik AGK Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Biomatik Main Business Overview
13.18.5 Biomatik Latest Developments
13.19 Biobyt
13.19.1 Biobyt Company Information
13.19.2 Biobyt AGK Antibody Product Portfolios and Specifications
13.19.3 Biobyt AGK Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Biobyt Main Business Overview
13.19.5 Biobyt Latest Developments
13.20 Jingjie PTM BioLab
13.20.1 Jingjie PTM BioLab Company Information
13.20.2 Jingjie PTM BioLab AGK Antibody Product Portfolios and Specifications
13.20.3 Jingjie PTM BioLab AGK Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Jingjie PTM BioLab Main Business Overview
13.20.5 Jingjie PTM BioLab Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. AGK Antibody Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. AGK Antibody Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Monoclonal
Table 4. Major Players of Polyclonal
Table 5. Global AGK Antibody Sales by Type (2018-2023) & (L)
Table 6. Global AGK Antibody Sales Market Share by Type (2018-2023)
Table 7. Global AGK Antibody Revenue by Type (2018-2023) & ($ million)
Table 8. Global AGK Antibody Revenue Market Share by Type (2018-2023)
Table 9. Global AGK Antibody Sale Price by Type (2018-2023) & (US$/L)
Table 10. Global AGK Antibody Sales by Application (2018-2023) & (L)
Table 11. Global AGK Antibody Sales Market Share by Application (2018-2023)
Table 12. Global AGK Antibody Revenue by Application (2018-2023)
Table 13. Global AGK Antibody Revenue Market Share by Application (2018-2023)
Table 14. Global AGK Antibody Sale Price by Application (2018-2023) & (US$/L)
Table 15. Global AGK Antibody Sales by Company (2018-2023) & (L)
Table 16. Global AGK Antibody Sales Market Share by Company (2018-2023)
Table 17. Global AGK Antibody Revenue by Company (2018-2023) ($ Millions)
Table 18. Global AGK Antibody Revenue Market Share by Company (2018-2023)
Table 19. Global AGK Antibody Sale Price by Company (2018-2023) & (US$/L)
Table 20. Key Manufacturers AGK Antibody Producing Area Distribution and Sales Area
Table 21. Players AGK Antibody Products Offered
Table 22. AGK Antibody Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global AGK Antibody Sales by Geographic Region (2018-2023) & (L)
Table 26. Global AGK Antibody Sales Market Share Geographic Region (2018-2023)
Table 27. Global AGK Antibody Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global AGK Antibody Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global AGK Antibody Sales by Country/Region (2018-2023) & (L)
Table 30. Global AGK Antibody Sales Market Share by Country/Region (2018-2023)
Table 31. Global AGK Antibody Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global AGK Antibody Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas AGK Antibody Sales by Country (2018-2023) & (L)
Table 34. Americas AGK Antibody Sales Market Share by Country (2018-2023)
Table 35. Americas AGK Antibody Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas AGK Antibody Revenue Market Share by Country (2018-2023)
Table 37. Americas AGK Antibody Sales by Type (2018-2023) & (L)
Table 38. Americas AGK Antibody Sales by Application (2018-2023) & (L)
Table 39. APAC AGK Antibody Sales by Region (2018-2023) & (L)
Table 40. APAC AGK Antibody Sales Market Share by Region (2018-2023)
Table 41. APAC AGK Antibody Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC AGK Antibody Revenue Market Share by Region (2018-2023)
Table 43. APAC AGK Antibody Sales by Type (2018-2023) & (L)
Table 44. APAC AGK Antibody Sales by Application (2018-2023) & (L)
Table 45. Europe AGK Antibody Sales by Country (2018-2023) & (L)
Table 46. Europe AGK Antibody Sales Market Share by Country (2018-2023)
Table 47. Europe AGK Antibody Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe AGK Antibody Revenue Market Share by Country (2018-2023)
Table 49. Europe AGK Antibody Sales by Type (2018-2023) & (L)
Table 50. Europe AGK Antibody Sales by Application (2018-2023) & (L)
Table 51. Middle East & Africa AGK Antibody Sales by Country (2018-2023) & (L)
Table 52. Middle East & Africa AGK Antibody Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa AGK Antibody Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa AGK Antibody Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa AGK Antibody Sales by Type (2018-2023) & (L)
Table 56. Middle East & Africa AGK Antibody Sales by Application (2018-2023) & (L)
Table 57. Key Market Drivers & Growth Opportunities of AGK Antibody
Table 58. Key Market Challenges & Risks of AGK Antibody
Table 59. Key Industry Trends of AGK Antibody
Table 60. AGK Antibody Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. AGK Antibody Distributors List
Table 63. AGK Antibody Customer List
Table 64. Global AGK Antibody Sales Forecast by Region (2024-2029) & (L)
Table 65. Global AGK Antibody Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas AGK Antibody Sales Forecast by Country (2024-2029) & (L)
Table 67. Americas AGK Antibody Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC AGK Antibody Sales Forecast by Region (2024-2029) & (L)
Table 69. APAC AGK Antibody Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe AGK Antibody Sales Forecast by Country (2024-2029) & (L)
Table 71. Europe AGK Antibody Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa AGK Antibody Sales Forecast by Country (2024-2029) & (L)
Table 73. Middle East & Africa AGK Antibody Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global AGK Antibody Sales Forecast by Type (2024-2029) & (L)
Table 75. Global AGK Antibody Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global AGK Antibody Sales Forecast by Application (2024-2029) & (L)
Table 77. Global AGK Antibody Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Merck Basic Information, AGK Antibody Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck AGK Antibody Product Portfolios and Specifications
Table 80. Merck AGK Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 81. Merck Main Business
Table 82. Merck Latest Developments
Table 83. Thermo Fisher Scientific Basic Information, AGK Antibody Manufacturing Base, Sales Area and Its Competitors
Table 84. Thermo Fisher Scientific AGK Antibody Product Portfolios and Specifications
Table 85. Thermo Fisher Scientific AGK Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 86. Thermo Fisher Scientific Main Business
Table 87. Thermo Fisher Scientific Latest Developments
Table 88. LifeSpan BioSciences Basic Information, AGK Antibody Manufacturing Base, Sales Area and Its Competitors
Table 89. LifeSpan BioSciences AGK Antibody Product Portfolios and Specifications
Table 90. LifeSpan BioSciences AGK Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 91. LifeSpan BioSciences Main Business
Table 92. LifeSpan BioSciences Latest Developments
Table 93. Aviva Systems Biology Basic Information, AGK Antibody Manufacturing Base, Sales Area and Its Competitors
Table 94. Aviva Systems Biology AGK Antibody Product Portfolios and Specifications
Table 95. Aviva Systems Biology AGK Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 96. Aviva Systems Biology Main Business
Table 97. Aviva Systems Biology Latest Developments
Table 98. RayBiotech Basic Information, AGK Antibody Manufacturing Base, Sales Area and Its Competitors
Table 99. RayBiotech AGK Antibody Product Portfolios and Specifications
Table 100. RayBiotech AGK Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 101. RayBiotech Main Business
Table 102. RayBiotech Latest Developments
Table 103. ProSci Basic Information, AGK Antibody Manufacturing Base, Sales Area and Its Competitors
Table 104. ProSci AGK Antibody Product Portfolios and Specifications
Table 105. ProSci AGK Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 106. ProSci Main Business
Table 107. ProSci Latest Developments
Table 108. OriGene Technologies Basic Information, AGK Antibody Manufacturing Base, Sales Area and Its Competitors
Table 109. OriGene Technologies AGK Antibody Product Portfolios and Specifications
Table 110. OriGene Technologies AGK Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 111. OriGene Technologies Main Business
Table 112. OriGene Technologies Latest Developments
Table 113. ABclonal Technology Basic Information, AGK Antibody Manufacturing Base, Sales Area and Its Competitors
Table 114. ABclonal Technology AGK Antibody Product Portfolios and Specifications
Table 115. ABclonal Technology AGK Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 116. ABclonal Technology Main Business
Table 117. ABclonal Technology Latest Developments
Table 118. Affinity Biosciences Basic Information, AGK Antibody Manufacturing Base, Sales Area and Its Competitors
Table 119. Affinity Biosciences AGK Antibody Product Portfolios and Specifications
Table 120. Affinity Biosciences AGK Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 121. Affinity Biosciences Main Business
Table 122. Affinity Biosciences Latest Developments
Table 123. Abbexa Basic Information, AGK Antibody Manufacturing Base, Sales Area and Its Competitors
Table 124. Abbexa AGK Antibody Product Portfolios and Specifications
Table 125. Abbexa AGK Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 126. Abbexa Main Business
Table 127. Abbexa Latest Developments
Table 128. Cell Signaling Technology Basic Information, AGK Antibody Manufacturing Base, Sales Area and Its Competitors
Table 129. Cell Signaling Technology AGK Antibody Product Portfolios and Specifications
Table 130. Cell Signaling Technology AGK Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 131. Cell Signaling Technology Main Business
Table 132. Cell Signaling Technology Latest Developments
Table 133. CUSABIO Technology Basic Information, AGK Antibody Manufacturing Base, Sales Area and Its Competitors
Table 134. CUSABIO Technology AGK Antibody Product Portfolios and Specifications
Table 135. CUSABIO Technology AGK Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 136. CUSABIO Technology Main Business
Table 137. CUSABIO Technology Latest Developments
Table 138. GeneTex Basic Information, AGK Antibody Manufacturing Base, Sales Area and Its Competitors
Table 139. GeneTex AGK Antibody Product Portfolios and Specifications
Table 140. GeneTex AGK Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 141. GeneTex Main Business
Table 142. GeneTex Latest Developments
Table 143. Leading Biology Basic Information, AGK Antibody Manufacturing Base, Sales Area and Its Competitors
Table 144. Leading Biology AGK Antibody Product Portfolios and Specifications
Table 145. Leading Biology AGK Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 146. Leading Biology Main Business
Table 147. Leading Biology Latest Developments
Table 148. Novus Biologicals Basic Information, AGK Antibody Manufacturing Base, Sales Area and Its Competitors
Table 149. Novus Biologicals AGK Antibody Product Portfolios and Specifications
Table 150. Novus Biologicals AGK Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 151. Novus Biologicals Main Business
Table 152. Novus Biologicals Latest Developments
Table 153. G Biosciences Basic Information, AGK Antibody Manufacturing Base, Sales Area and Its Competitors
Table 154. G Biosciences AGK Antibody Product Portfolios and Specifications
Table 155. G Biosciences AGK Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 156. G Biosciences Main Business
Table 157. G Biosciences Latest Developments
Table 158. Santa Cruz Biotechnology Basic Information, AGK Antibody Manufacturing Base, Sales Area and Its Competitors
Table 159. Santa Cruz Biotechnology AGK Antibody Product Portfolios and Specifications
Table 160. Santa Cruz Biotechnology AGK Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 161. Santa Cruz Biotechnology Main Business
Table 162. Santa Cruz Biotechnology Latest Developments
Table 163. Biomatik Basic Information, AGK Antibody Manufacturing Base, Sales Area and Its Competitors
Table 164. Biomatik AGK Antibody Product Portfolios and Specifications
Table 165. Biomatik AGK Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 166. Biomatik Main Business
Table 167. Biomatik Latest Developments
Table 168. Biobyt Basic Information, AGK Antibody Manufacturing Base, Sales Area and Its Competitors
Table 169. Biobyt AGK Antibody Product Portfolios and Specifications
Table 170. Biobyt AGK Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 171. Biobyt Main Business
Table 172. Biobyt Latest Developments
Table 173. Jingjie PTM BioLab Basic Information, AGK Antibody Manufacturing Base, Sales Area and Its Competitors
Table 174. Jingjie PTM BioLab AGK Antibody Product Portfolios and Specifications
Table 175. Jingjie PTM BioLab AGK Antibody Sales (L), Revenue ($ Million), Price (US$/L) and Gross Margin (2018-2023)
Table 176. Jingjie PTM BioLab Main Business
Table 177. Jingjie PTM BioLab Latest Developments
List of Figures
Figure 1. Picture of AGK Antibody
Figure 2. AGK Antibody Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global AGK Antibody Sales Growth Rate 2018-2029 (L)
Figure 7. Global AGK Antibody Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. AGK Antibody Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Monoclonal
Figure 10. Product Picture of Polyclonal
Figure 11. Global AGK Antibody Sales Market Share by Type in 2022
Figure 12. Global AGK Antibody Revenue Market Share by Type (2018-2023)
Figure 13. AGK Antibody Consumed in Immunochemistry (IHC)
Figure 14. Global AGK Antibody Market: Immunochemistry (IHC) (2018-2023) & (L)
Figure 15. AGK Antibody Consumed in Immunofluorescence (IF)
Figure 16. Global AGK Antibody Market: Immunofluorescence (IF) (2018-2023) & (L)
Figure 17. AGK Antibody Consumed in Immunoprecipitation (IP)
Figure 18. Global AGK Antibody Market: Immunoprecipitation (IP) (2018-2023) & (L)
Figure 19. AGK Antibody Consumed in Western Blot (WB)
Figure 20. Global AGK Antibody Market: Western Blot (WB) (2018-2023) & (L)
Figure 21. AGK Antibody Consumed in ELISA
Figure 22. Global AGK Antibody Market: ELISA (2018-2023) & (L)
Figure 23. AGK Antibody Consumed in Others
Figure 24. Global AGK Antibody Market: Others (2018-2023) & (L)
Figure 25. Global AGK Antibody Sales Market Share by Application (2022)
Figure 26. Global AGK Antibody Revenue Market Share by Application in 2022
Figure 27. AGK Antibody Sales Market by Company in 2022 (L)
Figure 28. Global AGK Antibody Sales Market Share by Company in 2022
Figure 29. AGK Antibody Revenue Market by Company in 2022 ($ Million)
Figure 30. Global AGK Antibody Revenue Market Share by Company in 2022
Figure 31. Global AGK Antibody Sales Market Share by Geographic Region (2018-2023)
Figure 32. Global AGK Antibody Revenue Market Share by Geographic Region in 2022
Figure 33. Americas AGK Antibody Sales 2018-2023 (L)
Figure 34. Americas AGK Antibody Revenue 2018-2023 ($ Millions)
Figure 35. APAC AGK Antibody Sales 2018-2023 (L)
Figure 36. APAC AGK Antibody Revenue 2018-2023 ($ Millions)
Figure 37. Europe AGK Antibody Sales 2018-2023 (L)
Figure 38. Europe AGK Antibody Revenue 2018-2023 ($ Millions)
Figure 39. Middle East & Africa AGK Antibody Sales 2018-2023 (L)
Figure 40. Middle East & Africa AGK Antibody Revenue 2018-2023 ($ Millions)
Figure 41. Americas AGK Antibody Sales Market Share by Country in 2022
Figure 42. Americas AGK Antibody Revenue Market Share by Country in 2022
Figure 43. Americas AGK Antibody Sales Market Share by Type (2018-2023)
Figure 44. Americas AGK Antibody Sales Market Share by Application (2018-2023)
Figure 45. United States AGK Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 46. Canada AGK Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 47. Mexico AGK Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 48. Brazil AGK Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 49. APAC AGK Antibody Sales Market Share by Region in 2022
Figure 50. APAC AGK Antibody Revenue Market Share by Regions in 2022
Figure 51. APAC AGK Antibody Sales Market Share by Type (2018-2023)
Figure 52. APAC AGK Antibody Sales Market Share by Application (2018-2023)
Figure 53. China AGK Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 54. Japan AGK Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 55. South Korea AGK Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 56. Southeast Asia AGK Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 57. India AGK Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 58. Australia AGK Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 59. China Taiwan AGK Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 60. Europe AGK Antibody Sales Market Share by Country in 2022
Figure 61. Europe AGK Antibody Revenue Market Share by Country in 2022
Figure 62. Europe AGK Antibody Sales Market Share by Type (2018-2023)
Figure 63. Europe AGK Antibody Sales Market Share by Application (2018-2023)
Figure 64. Germany AGK Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 65. France AGK Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 66. UK AGK Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 67. Italy AGK Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 68. Russia AGK Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 69. Middle East & Africa AGK Antibody Sales Market Share by Country in 2022
Figure 70. Middle East & Africa AGK Antibody Revenue Market Share by Country in 2022
Figure 71. Middle East & Africa AGK Antibody Sales Market Share by Type (2018-2023)
Figure 72. Middle East & Africa AGK Antibody Sales Market Share by Application (2018-2023)
Figure 73. Egypt AGK Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 74. South Africa AGK Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 75. Israel AGK Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 76. Turkey AGK Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 77. GCC Country AGK Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of AGK Antibody in 2022
Figure 79. Manufacturing Process Analysis of AGK Antibody
Figure 80. Industry Chain Structure of AGK Antibody
Figure 81. Channels of Distribution
Figure 82. Global AGK Antibody Sales Market Forecast by Region (2024-2029)
Figure 83. Global AGK Antibody Revenue Market Share Forecast by Region (2024-2029)
Figure 84. Global AGK Antibody Sales Market Share Forecast by Type (2024-2029)
Figure 85. Global AGK Antibody Revenue Market Share Forecast by Type (2024-2029)
Figure 86. Global AGK Antibody Sales Market Share Forecast by Application (2024-2029)
Figure 87. Global AGK Antibody Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のAGK抗体市場予測 2023年-2029年] (コード:LP23DC08470)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のAGK抗体市場予測 2023年-2029年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆